BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 31069776)

  • 1. In Vivo Measurement of Redox-Regulated TG2 Activity.
    Melkonian AV; Weng N; Palanski BA; Khosla C
    Methods Mol Biol; 2019; 1967():263-274. PubMed ID: 31069776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of extracellular transglutaminase 2 by thioredoxin.
    Jin X; Stamnaes J; Klöck C; DiRaimondo TR; Sollid LM; Khosla C
    J Biol Chem; 2011 Oct; 286(43):37866-73. PubMed ID: 21908620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thioredoxin-1 Selectively Activates Transglutaminase 2 in the Extracellular Matrix of the Small Intestine: IMPLICATIONS FOR CELIAC DISEASE.
    Plugis NM; Palanski BA; Weng CH; Albertelli M; Khosla C
    J Biol Chem; 2017 Feb; 292(5):2000-2008. PubMed ID: 28003361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endoplasmic reticulum-resident protein 57 (ERp57) oxidatively inactivates human transglutaminase 2.
    Yi MC; Melkonian AV; Ousey JA; Khosla C
    J Biol Chem; 2018 Feb; 293(8):2640-2649. PubMed ID: 29305423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redox regulation of transglutaminase 2 activity.
    Stamnaes J; Pinkas DM; Fleckenstein B; Khosla C; Sollid LM
    J Biol Chem; 2010 Aug; 285(33):25402-9. PubMed ID: 20547769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective inhibition of extracellular thioredoxin by asymmetric disulfides.
    DiRaimondo TR; Plugis NM; Jin X; Khosla C
    J Med Chem; 2013 Feb; 56(3):1301-10. PubMed ID: 23327656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cystamine and Disulfiram Inhibit Human Transglutaminase 2 via an Oxidative Mechanism.
    Palanski BA; Khosla C
    Biochemistry; 2018 Jun; 57(24):3359-3363. PubMed ID: 29570977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of transglutaminase activity using click chemistry.
    van Geel R; Debets MF; Löwik DW; Pruijn GJ; Boelens WC
    Amino Acids; 2012 Sep; 43(3):1251-63. PubMed ID: 22180026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the Catalytic Activity of Transglutaminases in the Context of Autophagic Responses.
    D'Eletto M; Farrace MG; Piacentini M; Rossin F
    Methods Enzymol; 2017; 587():511-520. PubMed ID: 28253975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative characterization of direct and indirect substrate probes for on-chip transamidating activity assay of transglutaminases.
    Lee K; Jung SH; Kong DH; Hwang BM; Han ET; Park SW; Park JH; Kim YM; Ha KS
    J Biotechnol; 2013 Dec; 168(4):324-30. PubMed ID: 24140601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of Transglutaminase 2 conformational changes in living cell.
    Pavlyukov MS; Antipova NV; Balashova MV; Shakhparonov MI
    Biochem Biophys Res Commun; 2012 May; 421(4):773-9. PubMed ID: 22548802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of human transglutaminase 2 in complex with adenosine triphosphate.
    Han BG; Cho JW; Cho YD; Jeong KC; Kim SY; Lee BI
    Int J Biol Macromol; 2010 Aug; 47(2):190-5. PubMed ID: 20450932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transglutaminase 2: a multi-functional protein in multiple subcellular compartments.
    Park D; Choi SS; Ha KS
    Amino Acids; 2010 Aug; 39(3):619-31. PubMed ID: 20148342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transglutaminase 2 strongly binds to an extracellular matrix component other than fibronectin via its second C-terminal beta-barrel domain.
    Stamnaes J; Cardoso I; Iversen R; Sollid LM
    FEBS J; 2016 Nov; 283(21):3994-4010. PubMed ID: 27685605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Unusual "OR" Gate for Allosteric Regulation of Mammalian Transglutaminase 2 in the Extracellular Matrix.
    Melkonian AV; Loppinet E; Martin R; Porteus M; Khosla C
    J Am Chem Soc; 2021 Jul; 143(28):10537-10540. PubMed ID: 34232639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An unprecedented dual antagonist and agonist of human Transglutaminase 2.
    Yi MC; Palanski BA; Quintero SA; Plugis NM; Khosla C
    Bioorg Med Chem Lett; 2015 Nov; 25(21):4922-4926. PubMed ID: 26004580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural elements responsible for transglutaminase activity of protein disulphide isomerases and thioredoxins.
    Blaskó B; Mádi A; Fésüs L
    J Biol Regul Homeost Agents; 2004; 18(1):1-8. PubMed ID: 15323354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of transglutaminase 2 by nerve growth factor in differentiating neuroblastoma cells: A role in cell survival and neurite outgrowth.
    Algarni AS; Hargreaves AJ; Dickenson JM
    Eur J Pharmacol; 2018 Feb; 820():113-129. PubMed ID: 29242118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dermatan sulfate is a player in the transglutaminase 2 interaction network.
    Wisowski G; Koźma EM; Bielecki T; Pudełko A; Olczyk K
    PLoS One; 2017; 12(2):e0172263. PubMed ID: 28199387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of allosteric regulation of transglutaminase 2 by GTP.
    Begg GE; Carrington L; Stokes PH; Matthews JM; Wouters MA; Husain A; Lorand L; Iismaa SE; Graham RM
    Proc Natl Acad Sci U S A; 2006 Dec; 103(52):19683-8. PubMed ID: 17179049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.